Provider Training Methods for Fetal Alcohol Spectrum Disorders
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to test a new provider-assisted version of the caregiver Families Moving Forward (FMF) Connect app ("FMF Connect Pro") with mental health providers in the United States. In FMF Connect Pro, mental health providers learn to do routine screening for prenatal alcohol exposure, diagnose fetal alcohol spectrum disorders (FASD), and support families in using the FMF Connect caregiver app. Two different training methods will be compared with a waitlist group in this study. The first training method involves 13-sessions of tele-mentoring using an Extension of Community Healthcare Outcomes (ECHO) approach. The second training method involves a self-directed approach in which providers will access similar content in any asynchronous format on a website. The main questions this study aims to answer are: * What is the proportion of agencies and providers who accept and participate in the clinical trial (Reach)? * Do study groups differ on provider outcome measures of Effectiveness (clients screened/diagnosed), Adoption (provider change in knowledge, self-efficacy), Implementation (practice change, FMF Connect Pro Dashboard usage), and Maintenance of FASD-informed care practice change? All mental health providers in the study will complete online assessments at study entry, 6 months, and 12 months.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment ECHO implementation for Fetal Alcohol Spectrum Disorders?
The Families Moving Forward (FMF) Connect, a mobile health intervention derived from the FMF Program, shows promise in improving accessibility to FASD-informed care for caregivers, suggesting that similar approaches like ECHO implementation could be effective in supporting families dealing with FASD.12345
Is the Families Moving Forward Connect Pro intervention safe for humans?
How is the treatment for fetal alcohol spectrum disorders using ECHO implementation and FMF Connect Pro different from other treatments?
This treatment is unique because it focuses on training healthcare providers using the ECHO (Extension of Community Healthcare Outcomes) approach and FMF Connect Pro, which are designed to improve the knowledge and skills of professionals in managing fetal alcohol spectrum disorders. Unlike traditional treatments, this method emphasizes education and support for healthcare providers to ensure accurate diagnosis and effective care for affected individuals and their families.2891011
Eligibility Criteria
This trial is for mental health providers in the U.S. who work with children aged 3 to 12 or their families, are fluent in English, and have internet access. It's not for those working outside the U.S. or who don't serve this age group.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Training
Mental health providers are trained in FMF Connect Pro using either ECHO tele-mentoring or self-directed materials
Follow-up
Participants are monitored for changes in FASD-informed practice and effectiveness of the training
Waitlist Implementation
Waitlist group receives FMF Connect Pro via self-directed materials after 6-month assessments
Treatment Details
Interventions
- ECHO implementation
- FMF Connect Pro
- Self-Directed Learning implementation
ECHO implementation is already approved in United States for the following indications:
- Training for mental health providers in prenatal alcohol exposure screening and FASD diagnosis
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Rochester
Lead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator